Financial Consulate’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Financial Consulate’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.7K	Hold	345	–	–	﹤0.01%	629
2026 Q1	$10.4K	Sell	345 -12	-3%	-$386	﹤0.01%	630
2025 Q4	$11.1K	Buy	357 +270	+310%	+$6.65K	﹤0.01%	595
2025 Q3	$1.76K	Buy	+87	New	+$1.53K	﹤0.01%	798

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Financial Consulate's TEVA Position: Q2 2026 in Review

Financial Consulate held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q2 2026 at 345 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #629.

Financial Consulate first reported a position in TEVA in Q3 2025 and has held it in 4 quarters since. 677 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Financial Consulate held 345 shares of Teva Pharmaceutical Industries Limited worth $11.7K as of Q2 2026.
Financial Consulate left its Teva Pharmaceutical Industries Limited share count unchanged in Q2 2026.
Teva Pharmaceutical Industries Limited made up ﹤0.01% of Financial Consulate's portfolio in Q2 2026, its #629 holding.
Financial Consulate first reported a position in Teva Pharmaceutical Industries Limited in Q3 2025 and has held it in 4 quarters since.
677 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Financial Consulate's 13F filing for Q2 2026, filed 23 Jul 2026.